Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep 5;12(9):e0182118.
doi: 10.1371/journal.pone.0182118. eCollection 2017.

Preoperative asymptomatic leukocytosis and postoperative outcome in cardiac surgery patients

Affiliations

Preoperative asymptomatic leukocytosis and postoperative outcome in cardiac surgery patients

Eitezaz Mahmood et al. PLoS One. .

Abstract

Background: Despite showing a prognostic value in general surgical patients, preoperative asymptomatic elevated white blood cell (WBC) count is not considered a risk factor for cardiac surgery. Whereas there is sporadic evidence of its value as a preoperative risk marker, it has not been looked at methodically as a specific index of outcome during cardiac surgery. Using a national database we sought to determine the relationship between preoperative WBC count and postoperative outcome in cardiac surgical patients.

Methods: Cardiac surgeries were extracted from the 2007-2013 American College of Surgeons National Surgical Quality Improvement Program database. Leukocytosis was defined by a preoperative WBC count greater than 11,000 cells/μL. A univariate analysis compared the incidence of adverse outcomes for patients with and without leukocytosis. A multivariate logistic regression model was constructed in order to test whether leukocytosis was an independent predictor of morbidity and mortality.

Results: Out of a total of 10,979 cardiac surgery patients 863 (7.8%) had preoperative leukocytosis. On univariate analysis, patients with leukocytosis experienced greater incidences of 30-day mortality, wound complications, and medical complications. Wound complications included surgical site infection as well as wound dehiscence. The medical complications included all other non-surgical causes of increased morbidity and infection leading to urinary tract infection, pneumonia, ventilator dependence, sepsis and septic shock. After stepwise model adjustment, leukocytosis was a strong predictor of medical complications (OR 1.22, 95% CI: 1.09-1.36, p = 0.002) with c-statistic of 0.667. However, after stepwise model adjustment leukocytosis was not a significant predictor of 30-day mortality and wound complications.

Conclusion: Preoperative leukocytosis is associated with adverse postoperative outcome after cardiac surgery and is an independent predictor of infection-related postoperative complications.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. 30-day mortality vs. white blood cell count.
Stepwise plot of 30-day mortality rate against white blood cell count for the sample of 10,979 cardiac surgery patients, illustrating a positive relationship between the two variables.
Fig 2
Fig 2. Wound complications vs. white blood cell count.
Stepwise plot of wound complications rate against white blood cell count for the sample of 10,979 cardiac surgery patients, illustrating a positive relationship between the two variables.
Fig 3
Fig 3. Medical complications vs. white blood cell count.
Stepwise plot of medical complications rate against white blood cell count for the sample of 10,979 cardiac surgery patients, illustrating a positive relationship between the two variables.

Similar articles

Cited by

References

    1. Lindner HA, Balaban Ü, Sturm T, Wei C, Thiel M, Schneider-Lindner V. An Algorithm for Systemic Inflammatory Response Syndrome Criteria-Based Prediction of Sepsis in a Polytrauma Cohort. Crit Care Med. 2016. doi: 10.1097/CCM.0000000000001955 - DOI - PubMed
    1. Davies MG, Hagen PO. Systemic inflammatory response syndrome. Br J Surg. 1997;84: 920–935. - PubMed
    1. Walport MJ. Complement. First of two parts. N Engl J Med. 2001;344: 1058–1066. doi: 10.1056/NEJM200104053441406 - DOI - PubMed
    1. Walport MJ. Complement. Second of two parts. N Engl J Med. 2001;344: 1140–1144. doi: 10.1056/NEJM200104123441506 - DOI - PubMed
    1. Durandy Y. Minimizing systemic inflammation during cardiopulmonary bypass in the pediatric population. Artif Organs. 2014;38: 11–18. doi: 10.1111/aor.12195 - DOI - PubMed